Panel set to highlight clinical trials transformation

February 20, 2018  //  FOUND IN: Updates & Resources

As one of the medical directors of the Ambulatory & Chronic Disease Clinical Trials Support Unit (CTSU), Peter Higgins, M.D., and his study team were among the first to transition to the new clinical trials support system in early 2017, with a trial of the therapeutic Etrolizumab for the treatment of ulcerative colitis.

What were the hurdles Higgins and his study team faced — and surmounted — as early adopters of the new clinical trials system? How did the Ambulatory & Chronic Disease CTSU administration team help them work with other offices on campus, such as Finance? What’s it like using OnCore, the new clinical trials management system, on a daily basis?

You’re invited to join the Clinical Trials Support Office as it shines a spotlight on these questions and more, in an event featuring Higgins and project manager Kay Sauder in an engaging “talk-show style” panel discussion moderated by Connie Chang, managing director of Fast Forward Medical Innovation.

In addition to the panel discussion, hear the latest news from the Clinical Trials Support Office, including the upcoming transition of Cancer Center trials to the Oncology Clinical Trials Support Unit in late spring 2018 from Anna Lok, M.D., assistant dean for clinical research.

When: 3:30 p.m. – 4:30 p.m., Wednesday, Feb. 28

Where: Room M5330, Med Sci 1

Refreshments will be provided. Click here to RSVP.